1. Background {#sec103008}
=============

*Melissa officinalis*(*M. officinalis*) belongs to the genus *Melissa* (family Lamiaceae) ([@A27013R1]) known as "Badrangboya" in Persian, "Mufarrehal qhalb" and "Utrajul Raihath" in Arabic, "Billi lotan" in Hindi, "Mountain balm" and "Lemon balm" in English ([@A27013R2]). It is a salient medicinal and commercial herb popular worldwide ([@A27013R3]). *M. officinalis* is used in traditional medicine for various illnesses such as menstrual problems, hypertension, migraines, vertigo and fever ([@A27013R4], [@A27013R5]), depression and melancholy ([@A27013R4]), bronchitis and asthma ([@A27013R6]), eczema and gout ([@A27013R4]), epilepsy, paralysis, bell\'s palsy and arthritis ([@A27013R7]). Advanced researches showed its neuroprotective ([@A27013R8]), anxiolytic ([@A27013R9], [@A27013R10]), antispasmodic ([@A27013R11]), antihyperlipidemic and hepatoprotective effects ([@A27013R12]). The beneficial effect of lemon balm on Alzheimer's disease ([@A27013R13]) and heart palpitation was also reported ([@A27013R4]). Gazola et al. ([@A27013R14]) indicated negative chronotropic but no inotropic effect of *M. officinalis* extract on isolated rat heart. In an experimental study, we showed that acute injection of *M. officinalis* aqueous extract had a mild protective effect against reperfusion-induced lethal ventricular arrhythmias in rats ([@A27013R15]). Nowadays, *M. officinalis* is commonly used for its therapeutic properties; however, there is a lack of information about its long intake on electrical properties of the heart.

ECG is an easy, fast and valuable tool to evaluate the safety of used materials and drugs on heart electrical and conductivity properties. Many drugs with no cardiovascular indication or any overt cardiovascular effects of therapeutic dosing, become cardiotoxic when overdosed ([@A27013R16]). On the other hand, there are numerous substances and drugs that can cause ECG changes, even in patients without a history of cardiac disease.

2. Objectives {#sec103009}
=============

Therefore, this study was conducted to elucidate the safety and outcome of one-week administration of *M. officinalis* aqueous extract on blood pressure and ECG parameters of rats.

3. Materials and Methods {#sec103013}
========================

The present study was conducted in accordance with the guidelines of animal studies provided by the Ethics committee permission No K/90/486, Kerman University of Medical Sciences, Kerman, Iran.

3.1. Extract Preparation {#sec103010}
------------------------

*Melissa ofﬁcinalis* was collected in spring from Sirjan area (Kerman, Iran). After its identification, a voucher specimen (KF1429-1) was delivered to the Herbarium Center, Faculty of Pharmacy, and Kerman University of Medical Sciences. The dried aerial parts of the plants were ground and powdered to a particle size of about 0.5 mm. Later, 10 mL boiling distilled water was added to the powder and left for 10 minutes to brew the *M. officinalis*. The mixture was then filtered and its liquid evaporated under vacuum at 45 - 50°C. The resulting material was then dried completely at 70°C ([@A27013R14], [@A27013R15]). Finally, the prepared extract was stored in glass vials and kept at 20°C before use. On each day of the experiment, the required amounts of extract were weighed, dissolved in distilled water and then orally given to the animals.

3.2. Animals Groups and Experimental Protocol {#sec103011}
---------------------------------------------

Thirty-two male Wistar rats (250 - 300 grams) were purchased and kept in appropriate condition of temperature (21 ± 2°C), light-dark cycle (12/12 hour) and free access to rat regular diet and water. After adaptation, they were divided into four groups (8 in each) and were treated for seven days as: Control (CTL) group, which was gavaged with 1mL of distilled water/daily (equal to the volume of the extract), *Melissa officinalis* 50 (M 50), *Melissa officinalis*100 (M 100) and *Melissa officinalis* 200 (M 200) groups, which were gavaged with the aqueous extract of *Melissa officinalis* 50, 100 and200 mg/kg/daily, respectively. These doses of extract were chosen based on previous in vivo studies.

On the eighth day, animals were anesthetized with 50 mg/kg sodium thiopental (i.p.) ([@A27013R17]). Selection of the study period, surgical preparation and recording method of parameters were performed based on previous studies ([@A27013R18]). Briefly, the trachea of the animal was cannulated while spontaneous breathing was allowed throughout the experiment. The left common carotid artery was cannulated with a filled catheter (saline with 15 IU/mL heparin). The catheter was connected to a pressure transducer of a PowerLab system (AD Instruments, Australia) to allow arterial pressure recording. After connection of electrodes, standard limb lead II of ECG and arterial blood pressure (BP) were recorded following recovery time from surgery (15 minutes). ECG parameters (RR, PR, QRS, QTc, JT and TpTe intervals and waves amplitude) were assessed using ECG analysis module for PowerLab and LabChart from five minutes continuous ECG recorded strip. PR interval embraces the atrial depolarization (P wave) plus the duration of the electric current conduction through AV node and the specialized His-Purkinje system to the ventricles. It is the interval time from the P-wave onset to QRS complex (Q- or R wave) onset ([@A27013R19]). The QT interval includes both depolarization and repolarization of the heart and it is the interval time from the earliest Q or R-wave onset to the end of T wave. By using the Bazett's formula normalized as QTcn - B = QT/(RR/ f) ^1/2^, a modified and applicable formula for QT correction in rat, corrected QT (QTc) interval was calculated to prevent the dependence of QT interval on heart rate. RR is R-R interval and f = 150 ms ([@A27013R20]). JT interval an interval from junction point J to T wave end and T peak to T end interval (TpTe), the period from the peak of the T wave until the end of the T wave, were also calculated.

3.3. Statistical Analysis {#sec103012}
-------------------------

Data was shown as Mean ± SD. Normal distribution of data was confirmed by Kolmogorov-Smirnov test. One-way ANOVA and the post hoc Tukey test were used to compare data using IBM SPSS Statistics 20 for Windows (IBM Inc., Armonk, NY, USA). The significance level was set at 0.05.

4. Results {#sec103014}
==========

[Figure 1](#fig19693){ref-type="fig"} demonstrates samples of the traces of the arterial blood pressure and lead II of ECG recorded simultaneously in a rat selected from each of the animal groups. Administration of different doses of *M. officinalis* extract did not induce significant alteration in the heart rate and also RR interval, P duration, P amplitude, Q amplitude, R amplitude, S amplitude, T amplitude and ST height of ECG in rats. *M. officinalis* extract was associated with an incremental trend in PR interval; however, this alteration was not statistically significant ([Table 1](#tbl26502){ref-type="table"}). In addition, *M. officinalis* extract significantly prolonged the QRS interval (P \< 0.05 for M50 and M100 group and P \< 0.01 for M200 group versus CTL group, respectively, [Figure 2](#fig19694){ref-type="fig"}), the QTc and JT intervals (P \< 0.01 for different M groups than the CTL group, [Figures 3](#fig19695){ref-type="fig"} and [4](#fig19696){ref-type="fig"}), also the TpTe interval (P \< 0.001 when M groups were compared with the CTL group, [Figure 5](#fig19697){ref-type="fig"}). In the present study, different doses of *M. officinalis* extract had no significant effect on blood pressure ([Figure 6](#fig19698){ref-type="fig"}).

![The Strips of Arterial Blood Pressure and Lead II of ECG Simultaneously Recorded From an Animal in Each Group\
CTL: the control group, M50: animal group which received 50 mg/kg/day of *M. officinalis* extract, M100: animal group which received 100 mg/kg/day of *M. officinalis* extract, M200: animal group which received 200 mg/kg/day of *M. officinalis* extract.](cardiovascmed-04-02-27013-g001){#fig19693}

###### Heart Rate and Some ECG Parameters of Animal Groups ^[a](#fn25333){ref-type="table-fn"}^

  Groups                                              Number   Heart rate, Beat/Min   RR Interval, ms   PR Interval, ms   P Duration, ms   P Amplitude, mV   Q Amplitude, mV   R Amplitude, mV   S Amplitude, mV   ST Height, mV   T Amplitude, mV
  --------------------------------------------------- -------- ---------------------- ----------------- ----------------- ---------------- ----------------- ----------------- ----------------- ----------------- --------------- -----------------
  **CTL** ^**[b](#fn25334){ref-type="table-fn"}**^    8        393 ± 25               151 ± 13          42 ± 2            15 ± 4           0.09 ± 0.04       -0.02 ± 0.01      0.66 ± 0.24       -0.41 ± 0.15      0.03 ± 0.06     0.07 ± 0.08
  **M50** ^**[b](#fn25334){ref-type="table-fn"}**^    8        400 ± 45               152 ± 17          44 ± 4            18 ± 2           0.11 ± 0.03       -0.02 ± 0.02      0.78 ± 0.22       -0.32 ± 0.11      0.03 ± 0.04     0.08 ± 0.02
  **M100** ^**[b](#fn25334){ref-type="table-fn"}**^   8        395 ± 16               152 ± 6           46 ± 3            17 ± 3           0.13 ± 0.02       -0.02 ± 0.01      0.85 ± 0.19       -0.38 ± 0.09      0.04 ± 0.04     0.09 ± 0.02
  **M200** ^**[b](#fn25334){ref-type="table-fn"}**^   8        390 ± 31               155 ± 13          45 ± 4            16 ± 3           0.13 ± 0.02       -0.02 ± 0.01      0.84 ± 0.08       -0.37 ± 0.13      0.04 ± 0.05     0.09 ± 0.03

^a^Values are presented as Mean ± SD.

^b^CTL: control, M50: animal group which received 50 mg/kg/day of *M. officinalis* extract, M100: animal group which received 100 mg/kg/day of *M. officinalis* extract, M200: animal group which received 200 mg/kg/day of *M. officinalis* extract, n = 8. Differences were not significant among the groups.

![QRS Interval in All Groups\
Values are expressed in Mean ± SD, CTL: the control group, M50: animal group which received 50 mg/kg/day of *M. officinalis* extract, M100: animal group which received 100 mg/kg/day of *M. officinalis* extract, M200: animal group which received 200 mg/kg/day of *M. officinalis* extract. n = 8, \* P \< 0.05 and \*\* P \< 0.01 vs. CTL group.](cardiovascmed-04-02-27013-i001){#fig19694}

![Corrected QT Interval Measured Using the Bazett's Formula Normalized in Animals Groups\
Values are expressed in Mean ± SD, CTL: the control group, M50: animal group which received 50 mg/kg/day of *M. officinalis* extract, M100: animal group which received 100 mg/kg/day of *M. officinalis* extract, M200: animal group which received 200 mg/kg/day of *M. officinalis* extract. n = 8, \*\* P \< 0.01 vs. CTL group.](cardiovascmed-04-02-27013-i002){#fig19695}

![JT Interval in Animals Groups\
Values are expressed in Mean ± SD, CTL: the control group, M50: animal group which received 50 mg/kg/day of *M. officinalis* extract, M100: animal group which received 100 mg/kg/day of *M. officinalis* extract, M200: animal group which received 200 mg/kg/day of *M. officinalis* extract. n = 8, \*\* P \< 0.01 vs CTL group.](cardiovascmed-04-02-27013-i003){#fig19696}

![TpTe Interval in All Groups\
Values are expressed in Mean ± SD, CTL, the control group; M50: animal group which received 50 mg/kg/day of *M. officinalis* extract, M100: animal group which received 100 mg/kg/day of *M.officinalis*extract, M200: animal group which received 200 mg/kg/day of *M. officinalis* extract. n = 8. ● P \< 0.001 vs. CTL group.](cardiovascmed-04-02-27013-i004){#fig19697}

![Arterial Blood Pressure in Different Experimental Groups\
Values are Mean ± SD. CTL, the control group; M50: animal group which received 50 mg/kg/day of *M. officinalis* extract, M100: animal group which received 100 mg/kg/day of *M. officinalis* extract, M200: animal group which received 200 mg/kg/day of *M. officinalis* extract. n = 8.](cardiovascmed-04-02-27013-i005){#fig19698}

5. Discussion {#sec103015}
=============

This study was conducted to elucidate the effect of *M. officinalis* extract on BP and ECG parameters of rat heart. The results showed that compared to the control group, doses of 50, 100 and 200 (mg/kg/day) *M. officinalis* significantly increased QRS, QTc, TpTe and JT intervals in rats.

QRS complex indicates depolarization of ventricles and its prolongation may stem from a wide variety of processes involved in the conduction system, the myocardium or both. Hypertrophic or infiltrative diseases, drugs or focal damage from infarction may be associated with prolonged QRS ([@A27013R19]). Sodium channel blockers including some class IA or 1C antiarrhythmics by blocking inward sodium current, can slow depolarization, reduce conduction velocity, prolong the QRS interval and consequently it may increase the risk of arrhythmia ([@A27013R19], [@A27013R21]). Inward rectifier potassium channel blockers such as chloroquine cause a more positive resting membrane potential, partial inactivation of sodium channels and hence can prolong the QRS interval ([@A27013R22]).

Based on QRS interval prolongation induced by *M. officinalis* extract, it is possible that consumption of this extract can slow ventricular conductivity by blocking sodium or potassium (IK1) or both currents. The blockade of the sodium channels, in a manner similar to the action of Class 1 antiarrhythmic drugs, could be potentially an antiarrhythmic effect. However, in high dosage of these drugs, this beneficial effect may convert to an arrhythmogenic adverse effect.

QTc interval is equal to the sum of depolarization and repolarization periods of the heart. JT interval is an interval in electrocardiogram made from the junction point J to the T wave end and describes the duration of ventricular repolarization ([@A27013R23]). TpTe is a mark of transmural dissemination of repolarization in the left ventricle ([@A27013R24], [@A27013R25]). Some drugs or agents such as Class 3 antiarrhythmic drugs may induce QTc and JT prolongation by blocking the potassium channels ([@A27013R26]). However, very long QT interval may trigger early after-depolarizations (EADs), a phenomenon that may be associated with ventricular extrasystoles and in turn increase the risk of reentry and torsade de pointes (TdP) tachyarrhythmia ([@A27013R27]).

There are three cell types identified in the ventricular myocardium: the endocardial, epicardial and subendocardial M cells (Masonic mid-myocardial Moe cells) ([@A27013R28], [@A27013R29]). Likely, due to larger late sodium and sodium/calcium exchange currents and a weaker slowly activating delayed rectifier current (IKs) ([@A27013R30]), the action potential of the M cells is more vulnerable to prolongation compared to the other two cell types ([@A27013R25]). During the period of TpTe interval in which the epicardium has been repolarized, M cells are still in the process of repolarization and vulnerable to the occurrence of early after depolarizations (EADs) ([@A27013R31]) and in turn it can lead to reentry and consequently ventricular tachycardia or ventricular fibrillation. Therefore, prolongation of QRS, JT, QTc and TpTe intervals following *Melissa officinalis* pretreatment, can be a double-edged sword, indicating antiarrhythmic or proarrhythmic effect. If the proarrhythmic effect be dominant, it could increase the potential vulnerability to re-entry ventricular arrhythmias ([@A27013R32]-[@A27013R34]) and also elevate the risk of sudden cardiac death ([@A27013R35], [@A27013R36]). In this regard, we previously showed mild anti-arrhythmic effect of single doses of *Melissa officinalis*([@A27013R15]). Recent studies have also shown the electrophysiological effects of some herbal medicine, which led to expansion of our approach in the use of herbal medicines in the field of cardiac electrophysiology. Some examples include: (Ι) suppressing and preventing effect of Wenxin Keli, a herbal extract, on atrial and ventricular arrhythmias by depression of Ito and INa-dependent electrophysiological parameters ([@A27013R37], [@A27013R38]), (ΙΙ) anti-arrhythmic effect of saffron extract ([@A27013R39]) and its effects on the Wenckebach block cycle length and nodal functional refractory period in in vitro model ([@A27013R40]), (ΙΙΙ) anti-arrhythmic and electrophysiological effects of European *Lamiaceae Leonurus* cardiaca extract as calcium channels I (Ca.L) blockade, reduction of repolarizing current I (K.r) and prolongation of action potential duration ([@A27013R41]) and (IV) bidirectional tachycardia induced by aconites present in a Chinese herbal decoction ([@A27013R42]).

The present study demonstrated that a week consumption of *Melissa officinalis*, a famous well-known herbal medicine, can cause ECG alteration in rat. Changes included prolongation of QRS, QTc and JT and TpTe intervals. These effects may result from modulation in expression or conductance properties of involving ion channels in the heart. Further studies are necessary to elucidate the exact mechanisms and determine potential clinical outcomes.
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